Eleven Biotherapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Eleven Biotherapeutics Inc
CIK #0001485003
EDGAR Form CIK 2011 - 2026
10-K [0001485003]
10-Q [0001485003]
3 [0001485003]
4 [0001485003]
8-K [0001485003]
D [0001485003]
SC 13D [0001485003]
SC 13G [0001485003]
Form 13D/13G Filer Form 13D/13G Subject Filed
AbbVie Biotechnology Ltd Carisma Therapeutics Inc [2024-03-13]
Trustees of the University of Pennsylvania Carisma Therapeutics Inc [2023-03-17]
Longview Innovation Corp Carisma Therapeutics Inc [2023-03-16]
Modernatx Inc Carisma Therapeutics Inc [2023-03-13]
HealthCap VII LP Carisma Therapeutics Inc [2023-03-09]
Radoff Bradley Louis Sesen Bio Inc [2022-11-18]
BlackRock Inc Sesen Bio Inc [2022-07-08]
Vanguard Group Inc Sesen Bio Inc [2022-02-10]
BlackRock Inc Sesen Bio Inc [2022-02-04]
Integrated Assets II LLC Sesen Bio Inc [2021-06-28]
CVI Investments Inc Sesen Bio Inc [2019-06-28]
Consonance Capital Management LP Sesen Bio Inc [2019-02-14]
Kingdon Capital Management LLC Eleven Biotherapeutics Inc [2018-04-04]
Sabby Management LLC Eleven Biotherapeutics Inc [2018-03-22]
Empery Asset Management LP Eleven Biotherapeutics Inc [2017-11-08]
Dan Leslie Eleven Biotherapeutics Inc [2016-09-28]
Boxer Capital LLC Eleven Biotherapeutics Inc [2016-05-25]
Sabby Management LLC Eleven Biotherapeutics Inc [2016-02-01]
Franklin Resources Inc Eleven Biotherapeutics Inc [2015-12-10]
JAFCO Super V3 Investment Limited Partnership Eleven Biotherapeutics Inc [2015-02-13]
Sabby Management LLC Eleven Biotherapeutics Inc [2014-12-02]
FMR LLC Eleven Biotherapeutics Inc [2014-05-12]
Third Rock Ventures LP Eleven Biotherapeutics Inc [2014-02-21]
Broadfin Capital LLC Eleven Biotherapeutics Inc [2014-02-19]
Flagship Ventures Fund 2007 LP Eleven Biotherapeutics Inc [2014-02-13]
Form 3/4/5 Subject 2011 - 2026
Carisma Therapeutics Inc
Klichinsky Michael
Kelly Steven
McAndrew Natalie
Cheng Sohanya Roshan
Scadden David
Thorell Marella
Morrison Briggs
Zweifach Sanford S
Hohneker John
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Carisma Therapeutics Inc CARM
Common Stock
2025-10-07 Option exercise 56,982 $0.11 6,268
Carisma Therapeutics Inc CARM
Common Stock
2025-10-07 Sell 56,982 $0.25 14,246
Carisma Therapeutics Inc CARM
Stock Option (right to buy) · derivative
2025-10-07 Option exercise 56,982 $0.00
Carisma Therapeutics Inc CARM
Common Stock
2025-10-03 Sell 119,347 $0.26 31,030
Carisma Therapeutics Inc CARM
Common Stock
2025-10-02 Sell 200,000 $0.25 50,000
Carisma Therapeutics Inc CARM
Common Stock
2025-10-01 Sell 165,000 $0.26 42,900
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2025-01-28 Grant 500,000 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2025-01-28 Grant 221,000 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-10-31 Grant 38,700 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-07-01 Grant 38,700 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-07-01 Grant 38,700 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-26 Grant 19,350 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-26 Grant 19,350 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-26 Grant 19,350 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-26 Grant 19,350 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-17 Grant 85,000 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-17 Grant 85,000 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-06-17 Grant 125,000 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-04-01 Grant 38,700 $0.00
Carisma Therapeutics Inc CARM
Stock Option (Right to Buy) · derivative
2024-01-31 Grant 170,500 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com